Trodelvy 200mg (Sacituzumab govitecan-hziy Vials) 200mg

Trodelvy 200mg (sacituzumab govitecan-hziy) is a prescription medication supplied in 200mg vials. It is used under medical supervision for certain cancer treatments. Store between 2-8°C to maintain potency. Always follow healthcare provider instructions.

Strength

200mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Gilead Sciences

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trodelvy 200mg is used to treat specific types of metastatic cancers, including triple-negative breast cancer and urothelial carcinoma. It targets cancer cells using an antibody-drug conjugate approach. Patients should discuss suitability with their oncologist. This medication is not for all cancer types.

Side Effects

Trodelvy 200mg works by delivering chemotherapy directly to cancer cells, which may help reduce tumor size. Common effects include fatigue, nausea, and hair thinning. Some patients experience changes in blood cell counts. These effects vary by individual and treatment stage.

Precautions & Warnings

Trodelvy 200mg requires careful handling and storage at 2-8°C. Avoid freezing or exposure to high temperatures. Patients should report any signs of infection or unusual symptoms to their healthcare team. Regular blood tests are typically needed during treatment.

Avoid Interactions

Trodelvy may interact with medications that affect liver enzymes, such as strong CYP3A4 inhibitors or inducers. Combining with other cancer therapies should be managed by a doctor. Alcohol and certain supplements may also affect treatment outcomes. Always inform your healthcare provider about all medications.

Frequently Asked Questions

Trodelvy 200mg is used to treat certain metastatic cancers, including triple-negative breast cancer and urothelial carcinoma.

Trodelvy 200mg is administered as an intravenous infusion by a healthcare professional in a clinical setting.

Common side effects may include fatigue, nausea, and hair thinning. Some patients experience changes in blood cell counts.

No, Trodelvy 200mg should be stored between 2-8°C and protected from freezing.

Yes, Trodelvy may interact with medications that affect liver enzymes or other cancer therapies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.